Nontranslational function of leucyl-tRNA synthetase regulates myogenic differentiation and skeletal muscle regeneration

Kook Son, Jae Sung You, Mee Sup Yoon, Chong Dai, Jong Hyun Kim, Nidhi Khanna, Aditi Banerjee, Susan A Martinis, Gyoonhee Han, Jung Min Han, Sunghoon Kim, Jie Chen

Research output: Contribution to journalArticle

Abstract

Aside from its catalytic function in protein synthesis, leucyl-tRNA synthetase (LRS) has a nontranslational function in regulating cell growth via the mammalian target of rapamycin (mTOR) complex 1 (mTORC1) pathway by sensing amino acid availability. mTOR also regulates skeletal myogenesis, but the signaling mechanism is distinct from that in cell growth regulation. A role of LRS in myogenesis has not been reported. Here we report that LRS negatively regulated myoblast differentiation in vitro. This function of LRS was independent of its regulation of protein synthesis, and it required leucine-binding but not tRNA charging activity of LRS. Local knock down of LRS accelerated muscle regeneration in a mouse injury model, and so did the knock down of Rag or Raptor. Further in vitro studies established a Rag-mTORC1 pathway, which inhibits the IRS1-PI3K-Akt pathway, to be the mediator of the nontranslational function of LRS in myogenesis. BC-LI-0186, an inhibitor reported to disrupt LRS-Rag interaction, promoted robust muscle regeneration with enhanced functional recovery, and this effect was abolished by cotreatment with an Akt inhibitor. Taken together, our findings revealed what we believe is a novel function for LRS in controlling the homeostasis of myogenesis, and suggested a potential therapeutic strategy to target a noncanonical function of a housekeeping protein.

Original languageEnglish (US)
Pages (from-to)2088-2093
Number of pages6
JournalJournal of Clinical Investigation
Volume129
Issue number5
DOIs
StatePublished - May 1 2019

Fingerprint

Amino Acyl-tRNA Synthetases
Regeneration
Skeletal Muscle
Muscle Development
Transfer RNA Aminoacylation
Raptors
Housekeeping
Muscles
Proteins
Myoblasts
Sirolimus
Growth
Phosphatidylinositol 3-Kinases
Leucine
Homeostasis
Amino Acids

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Nontranslational function of leucyl-tRNA synthetase regulates myogenic differentiation and skeletal muscle regeneration. / Son, Kook; You, Jae Sung; Yoon, Mee Sup; Dai, Chong; Kim, Jong Hyun; Khanna, Nidhi; Banerjee, Aditi; Martinis, Susan A; Han, Gyoonhee; Han, Jung Min; Kim, Sunghoon; Chen, Jie.

In: Journal of Clinical Investigation, Vol. 129, No. 5, 01.05.2019, p. 2088-2093.

Research output: Contribution to journalArticle

Son, Kook ; You, Jae Sung ; Yoon, Mee Sup ; Dai, Chong ; Kim, Jong Hyun ; Khanna, Nidhi ; Banerjee, Aditi ; Martinis, Susan A ; Han, Gyoonhee ; Han, Jung Min ; Kim, Sunghoon ; Chen, Jie. / Nontranslational function of leucyl-tRNA synthetase regulates myogenic differentiation and skeletal muscle regeneration. In: Journal of Clinical Investigation. 2019 ; Vol. 129, No. 5. pp. 2088-2093.
@article{b79cec9f75f242ccbd1d9ee16055a005,
title = "Nontranslational function of leucyl-tRNA synthetase regulates myogenic differentiation and skeletal muscle regeneration",
abstract = "Aside from its catalytic function in protein synthesis, leucyl-tRNA synthetase (LRS) has a nontranslational function in regulating cell growth via the mammalian target of rapamycin (mTOR) complex 1 (mTORC1) pathway by sensing amino acid availability. mTOR also regulates skeletal myogenesis, but the signaling mechanism is distinct from that in cell growth regulation. A role of LRS in myogenesis has not been reported. Here we report that LRS negatively regulated myoblast differentiation in vitro. This function of LRS was independent of its regulation of protein synthesis, and it required leucine-binding but not tRNA charging activity of LRS. Local knock down of LRS accelerated muscle regeneration in a mouse injury model, and so did the knock down of Rag or Raptor. Further in vitro studies established a Rag-mTORC1 pathway, which inhibits the IRS1-PI3K-Akt pathway, to be the mediator of the nontranslational function of LRS in myogenesis. BC-LI-0186, an inhibitor reported to disrupt LRS-Rag interaction, promoted robust muscle regeneration with enhanced functional recovery, and this effect was abolished by cotreatment with an Akt inhibitor. Taken together, our findings revealed what we believe is a novel function for LRS in controlling the homeostasis of myogenesis, and suggested a potential therapeutic strategy to target a noncanonical function of a housekeeping protein.",
author = "Kook Son and You, {Jae Sung} and Yoon, {Mee Sup} and Chong Dai and Kim, {Jong Hyun} and Nidhi Khanna and Aditi Banerjee and Martinis, {Susan A} and Gyoonhee Han and Han, {Jung Min} and Sunghoon Kim and Jie Chen",
year = "2019",
month = "5",
day = "1",
doi = "10.1172/JCI122560",
language = "English (US)",
volume = "129",
pages = "2088--2093",
journal = "Journal of Clinical Investigation",
issn = "0021-9738",
publisher = "The American Society for Clinical Investigation",
number = "5",

}

TY - JOUR

T1 - Nontranslational function of leucyl-tRNA synthetase regulates myogenic differentiation and skeletal muscle regeneration

AU - Son, Kook

AU - You, Jae Sung

AU - Yoon, Mee Sup

AU - Dai, Chong

AU - Kim, Jong Hyun

AU - Khanna, Nidhi

AU - Banerjee, Aditi

AU - Martinis, Susan A

AU - Han, Gyoonhee

AU - Han, Jung Min

AU - Kim, Sunghoon

AU - Chen, Jie

PY - 2019/5/1

Y1 - 2019/5/1

N2 - Aside from its catalytic function in protein synthesis, leucyl-tRNA synthetase (LRS) has a nontranslational function in regulating cell growth via the mammalian target of rapamycin (mTOR) complex 1 (mTORC1) pathway by sensing amino acid availability. mTOR also regulates skeletal myogenesis, but the signaling mechanism is distinct from that in cell growth regulation. A role of LRS in myogenesis has not been reported. Here we report that LRS negatively regulated myoblast differentiation in vitro. This function of LRS was independent of its regulation of protein synthesis, and it required leucine-binding but not tRNA charging activity of LRS. Local knock down of LRS accelerated muscle regeneration in a mouse injury model, and so did the knock down of Rag or Raptor. Further in vitro studies established a Rag-mTORC1 pathway, which inhibits the IRS1-PI3K-Akt pathway, to be the mediator of the nontranslational function of LRS in myogenesis. BC-LI-0186, an inhibitor reported to disrupt LRS-Rag interaction, promoted robust muscle regeneration with enhanced functional recovery, and this effect was abolished by cotreatment with an Akt inhibitor. Taken together, our findings revealed what we believe is a novel function for LRS in controlling the homeostasis of myogenesis, and suggested a potential therapeutic strategy to target a noncanonical function of a housekeeping protein.

AB - Aside from its catalytic function in protein synthesis, leucyl-tRNA synthetase (LRS) has a nontranslational function in regulating cell growth via the mammalian target of rapamycin (mTOR) complex 1 (mTORC1) pathway by sensing amino acid availability. mTOR also regulates skeletal myogenesis, but the signaling mechanism is distinct from that in cell growth regulation. A role of LRS in myogenesis has not been reported. Here we report that LRS negatively regulated myoblast differentiation in vitro. This function of LRS was independent of its regulation of protein synthesis, and it required leucine-binding but not tRNA charging activity of LRS. Local knock down of LRS accelerated muscle regeneration in a mouse injury model, and so did the knock down of Rag or Raptor. Further in vitro studies established a Rag-mTORC1 pathway, which inhibits the IRS1-PI3K-Akt pathway, to be the mediator of the nontranslational function of LRS in myogenesis. BC-LI-0186, an inhibitor reported to disrupt LRS-Rag interaction, promoted robust muscle regeneration with enhanced functional recovery, and this effect was abolished by cotreatment with an Akt inhibitor. Taken together, our findings revealed what we believe is a novel function for LRS in controlling the homeostasis of myogenesis, and suggested a potential therapeutic strategy to target a noncanonical function of a housekeeping protein.

UR - http://www.scopus.com/inward/record.url?scp=85064853184&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85064853184&partnerID=8YFLogxK

U2 - 10.1172/JCI122560

DO - 10.1172/JCI122560

M3 - Article

VL - 129

SP - 2088

EP - 2093

JO - Journal of Clinical Investigation

JF - Journal of Clinical Investigation

SN - 0021-9738

IS - 5

ER -